Global Innovative Platforms (GIPL) Net Cash Flow (QoQ) (2021 - 2026)
Powered by 
Analysis
Global Innovative Platforms (GIPL) Net Cash Flow (QoQ) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -106.85% |
| Mar 31, 2026 | 245.25% |
| Dec 31, 2025 | -50.08% |
| Sep 30, 2025 | -1,416.69% |
| Jun 30, 2025 | -88.98% |
| Mar 31, 2025 | 268.60% |
| Dec 31, 2024 | 23.86% |
| Sep 30, 2024 | -3,225.09% |
| Jun 30, 2024 | 976.95% |
| Mar 31, 2024 | -185.75% |
| Dec 31, 2023 | 102.38% |
| Sep 30, 2023 | -1,956.46% |
| Jun 30, 2023 | 95.77% |
| Mar 31, 2023 | -469.11% |
| Dec 31, 2022 | -89.25% |
| Sep 30, 2021 | -198.60% |